Apyx Medical Corporation (APYX)

NASDAQ: APYX · Delayed Price · USD
3.70
0.26 (7.56%)
At close: May 25, 2022 4:00 PM
3.88
0.18 (4.86%)
After-hours:May 25, 2022 5:05 PM EDT

Company Description

Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide.

The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ablate soft tissue during open and laparoscopic surgical procedures.

The company offers Renuvion branded products for the cosmetic surgery market that enable plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and J-Plasma branded products for the hospital surgical market.

It also develops, manufactures, and sells disposable hand pieces, and OEM generators and accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019.

Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

Apyx Medical Corporation
Apyx Medical Logo
CountryUnited States
IPO DateJan 1, 1987
IndustryHealth Care Equipment & Supplies
SectorHealth Care
Employees272
CEOCharles Goodwin

Contact Details

Address:
5115 Ulmerton Rd
Clearwater, Florida 33760-4004
United States
Phone727 384 2323
Websiteapyxmedical.com

Stock Details

Ticker SymbolAPYX
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUS Dollars
CIK Code0000719135

Key Executives

NamePosition
Charles D. Goodwin IIPresident, Chief Executive Officer and Director
Tara H. SembChief Financial Officer, Treasurer and Secretary
Moshe CitronowiczSenior Vice President
Todd HornsbyExecutive Vice President

Latest SEC Filings

DateTypeTitle
May 19, 20224Statement of changes in beneficial ownership of securities
May 12, 202210-QQuarterly report [Sections 13 or 15(d)]
May 12, 20228-KCurrent report
Apr 4, 20228-KCurrent report
Mar 22, 20224Statement of changes in beneficial ownership of securities
Mar 21, 20228-K/ACurrent report
Mar 17, 202210-KAnnual report [Section 13 and 15(d), not S-K Item 405]
Mar 17, 20228-KCurrent report
Mar 14, 20228-KCurrent report
Feb 14, 2022SC 13G/AStatement of acquisition of beneficial ownership by individuals
View All SEC Filings